Cardiovascular: Palpitation, tachycardia, elevation of blood pressure.
Central Nervous System: Overstimulation, restlessness, dizziness, insomnia,
tremor, headache; rarely psychotic episodes at recommended doses, agitation,
flushing, sweating, blurring of vision.
Gastrointestinal: Dryness of the mouth, diarrhea, constipation, nausea,
stomach pain.
Genitourinary: Changes in libido, urinary frequency, dysuria.
Drug Abuse And Dependence
Controlled Substance: Phendimetrazine is a Schedule lll controlled substance.
Dependence: Phendimetrazine tartrate is related chemically and pharmacologically
to the amphetamines. Amphetamines and related stimulant drugs have been extensively
abused, and the possibility of abuse of phendimetrazine should be kept in mind
when evaluating the desirability of including a drug as part of a weight reduction
program. Abuse of amphetamines and related drugs may be associated with intense
psychological dependence and severe social dysfunction. There are reports of
patients who have increased the dosage to many times that recommended. Abrupt
cessation following prolonged high dosage administration results in extreme
fatigue and mental depression; changes are also noted on the sleep EEG. Manifestations
of chronic intoxication with anorectic drugs include severe dermatoses, marked
insomnia, irritability, hyperactivity and personality changes. The most severe
manifestation of chronic intoxications is psychosis, often clinically indistinguishable
from schizophrenia.